Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

12 November 2025 : Animal Research

[Retracted: 19 Feb 2026] Xiehuang San Extract Attenuates Insulin Resistance in Obese Rats via Gut Microbiota Modulation: Experimental Evidence

YuXin Yang ABCDEF 1, Yantong Liu EF 2, Gui-Ju Zhang EFG 1*

DOI: 10.12659/MSM.949151

Med Sci Monit 2025; 31:e949151

Retraction Notice: It appears that the authors have taken credit for research conducted by other scientists, and the paper is therefore being retracted. Reference: YuXin Yang, Yantong Liu, Gui-Ju Zhang. Xiehuang San Extract Attenuates Insulin Resistance in Obese Rats via Gut Microbiota Modulation: Experimental Evidence. Med Sci Monit, 2025; 31: e949151. DOI: 10.12659/MSM.949151

Abstract

BACKGROUND: Obesity-induced insulin resistance significantly contributes to the global increase in type 2 diabetes, with gut microbiota alterations playing a critical role. Traditional herbal formulations, such as Xiehuang San (XHS), have been used for centuries in Chinese medicine. However, their mechanisms – particularly via the gut-liver-metabolism axis – remain to be fully elucidated. This study aimed to evaluate the efficacy of XHS in improving insulin resistance through metabolic and microbial modulation.

MATERIAL AND METHODS: A high-fat diet-induced obese insulin-resistant rat model (n=30) was established using male rats. Rats were randomized into 6 groups and treated with low, medium, or high doses of XHS, metformin, or vehicle control via daily gavage for 8 weeks. Metabolic parameters, including fasting blood glucose (FBG), fasting insulin (FINS), the homeostatic model assessment for insulin resistance (HOMA-IR), oral glucose tolerance (OGTT), and insulin tolerance tests (ITT) were assessed. Liver histology and lipid profiles were analyzed, and 16S rRNA sequencing was used to examine gut microbiota composition.

RESULTS: XHS treatment significantly reduced FBG (~25%), FINS (~30%), and HOMA-IR scores compared with the model group (P<0.05), with effects comparable to metformin. OGTT and ITT improvements were dose-dependent. XHS also ameliorated hepatic steatosis and improved lipid profiles (eg, lowered triglycerides and low-density lipoprotein cholesterol, and elevated high-density lipoprotein cholesterol). Gut microbiota analysis revealed that XHS decreased the Firmicutes/Bacteroidetes ratio and selectively increased Bacteroides while reducing Escherichia-Shigella, suggesting a reshaping of microbial diversity and abundance.

CONCLUSIONS: These findings suggest that XHS may enhance insulin sensitivity and improve metabolic outcomes in obese rats, partly via gut microbiota modulation. Further studies are needed to isolate its active components, clarify molecular pathways, and evaluate translational relevance in human subjects.

Keywords: Retracted Publication

Med Sci Monit 2026; 32:e953162     https://medscimonit.com/abstract/index/idArt/953162
 
  • Download PDF
  • Order reprints
  • Export Article
  • Related articles
  • Share by email
  • Metrics

569 395

Related Articles Metrics Order reprints Share article Share by email

Editorial

01 January 2026 : Editorial  

Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and Screening

Dinah V. Parums ORCID logo

DOI: 10.12659/MSM.952454

Med Sci Monit 2026; 32:e952454

0:00

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750